Latest News in the pharma Industry

Top Stories

Prostate cancer drug market 'worth $9.1bn by 2021'

Prostate cancer drug market 'worth $9.1bn by 2021'

12 Nov 2012

Decision Resources' latest report looks at the prostate cancer drug market between now and 2021.

Read more 
AMD and DR drug market to reach $6.25bn by 2015

AMD and DR drug market to reach $6.25bn by 2015

12 Nov 2012

There is a strong and growing market for drugs to treat the eye diseases AMD and DR, analysts say

Read more 
Obama win keeps healthcare reforms at the forefront in US

Obama win keeps healthcare reforms at the forefront in US

12 Nov 2012

Healthcare reforms will remain on the agenda in the US after Barrack Obama wins a second term as president.

Read more 
Takeda to acquire Envoy Therapeutics

Takeda to acquire Envoy Therapeutics

12 Nov 2012

Takeda has announced the acquisition of Envoy Therapeutics for $140 million.

Read more 
Claris Lifesciences announces joint venture in India and emerging markets

Claris Lifesciences announces joint venture in India and emerging markets

12 Nov 2012

Claris, Otsuka Pharmaceutical and Mitsui have entered into a new joint venture.

Read more 
WIN Consortium announces collaboration with Pfizer

WIN Consortium announces collaboration with Pfizer

12 Nov 2012

The WIN Consortium has confirmed Pfizer as its first pharmaceutical partner.

Read more 
Construction to begin on world's largest chromatography lab

Construction to begin on world's largest chromatography lab

5 Nov 2012

Novasep intends to build the world's largest chromatography facility for pharmaceutical work.

Read more 
Report recommends patient-centric approach to encourage adherence

Report recommends patient-centric approach to encourage adherence

5 Nov 2012

Patient adherence to medication could be improved by adopting a more patient-centric approach, a report suggests.

Read more 
UK spending on new medicines is falling

UK spending on new medicines is falling

5 Nov 2012

The head of the ABPI has expressed concern at the UK's falling expenditure on new medicines.

Read more 
Watson sells Rugby OTC products and trademarks to Major Pharmaceuticals

Watson sells Rugby OTC products and trademarks to Major Pharmaceuticals

30 Oct 2012

Watson has sold its Rugby OTC product trademark and assets to the Harvard Drug Group.

Read more 
Bayer set to buy Schiff Nutrition International for $1.2bn

Bayer set to buy Schiff Nutrition International for $1.2bn

30 Oct 2012

Bayer has struck a deal to acquire US vitamin maker Schiff.

Read more 
BioRx receives Zemaira distribution rights

BioRx receives Zemaira distribution rights

30 Oct 2012

BioRx has been added to the distribution network for Zemaira.

Read more